Wealth Architects LLC Acquires Shares of 5,757 Astera Labs, Inc. (NASDAQ:ALAB)

Wealth Architects LLC acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,757 shares of the company’s stock, valued at approximately $763,000.

Other hedge funds have also recently modified their holdings of the company. Tidal Investments LLC grew its stake in shares of Astera Labs by 81.8% during the third quarter. Tidal Investments LLC now owns 45,298 shares of the company’s stock valued at $2,373,000 after buying an additional 20,388 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Astera Labs during the third quarter valued at approximately $530,000. Avior Wealth Management LLC bought a new position in shares of Astera Labs during the third quarter valued at approximately $361,000. Maverick Capital Ltd. grew its stake in shares of Astera Labs by 16.0% during the third quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock valued at $60,575,000 after buying an additional 159,480 shares during the last quarter. Finally, Bank of Hawaii bought a new position in shares of Astera Labs during the third quarter valued at approximately $1,409,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ALAB. Needham & Company LLC reaffirmed a “buy” rating and set a $140.00 target price on shares of Astera Labs in a research note on Tuesday, February 11th. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a research note on Tuesday, January 28th. Barclays increased their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Morgan Stanley dropped their price objective on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has an average rating of “Buy” and an average price target of $112.77.

Astera Labs Trading Up 10.5 %

Shares of ALAB opened at $72.18 on Monday. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $147.39. The stock has a fifty day moving average price of $97.61 and a 200-day moving average price of $88.63. The firm has a market cap of $11.70 billion and a PE ratio of -41.72.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. As a group, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling

In related news, CFO Michael Truett Tate sold 125,800 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $82.53, for a total value of $10,382,274.00. Following the completion of the transaction, the chief financial officer now owns 244,242 shares in the company, valued at $20,157,292.26. This trade represents a 34.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, General Counsel Philip Mazzara sold 50,000 shares of the firm’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $87.46, for a total value of $4,373,000.00. Following the completion of the transaction, the general counsel now owns 191,209 shares of the company’s stock, valued at $16,723,139.14. This trade represents a 20.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 570,990 shares of company stock worth $50,242,702 in the last 90 days.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.